当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:291.27亿  总市值:291.27亿
流通股本:28.53亿   总股本:28.53亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金6,458,518,085.229,091,346,599.2521,805,396,666.9814,161,860,008.8
收到的税费返还154,396,803.23598,220,147.3464,828,126.43294,464,499.66
收到其他与经营活动有关的现金176,776,894.44343,744,773.05235,310,258.0562,497,208.08
经营活动现金流入的平衡项目0000
经营活动现金流入小计6,789,691,782.8730,033,311,519.622,505,535,051.4614,518,821,716.54
购买商品、接受劳务支付的现金5,764,735,765.2221,211,308,539.8414,980,410,027.5310,398,031,332.6
支付给职工以及为职工支付的现金636,117,807.571,780,261,966.431,272,359,567.35810,587,228.81
支付的各项税费219,132,820.941,131,976,118.37857,421,066.71683,950,023.03
支付其他与经营活动有关的现金200,107,751.08680,827,810.08511,058,207.33355,760,838.78
经营活动现金流出的平衡项目0000
经营活动现金流出小计6,820,094,144.8124,804,374,434.7217,621,248,868.9212,248,329,423.22
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-30,402,361.945,228,937,084.884,884,286,182.542,270,492,293.32
二、投资活动产生的现金流量:
收回投资收到的现金65,493,055.5688,628,666.6729,660,00024,830,000
取得投资收益收到的现金1,702,976.8531,215,210.8-573,449.291,922,811.43
处置固定资产、无形资产和其他长期资产收回的现金净额638,0004,600,429.9217,363.7917,363.79
投资活动现金流入的平衡项目0000
投资活动现金流入小计67,834,032.41124,444,307.3929,103,914.526,770,175.22
购建固定资产、无形资产和其他长期资产支付的现金387,432,533.211,333,258,499.811,007,317,474.06794,748,567.88
投资支付的现金171,617,566.67266,053,482.02475,669,598.65670,675,154.23
支付其他与投资活动有关的现金596,64534,278,559.79-796,016
投资活动现金流出的平衡项目0000
投资活动现金流出小计559,646,744.881,633,590,541.621,482,987,072.711,466,219,738.11
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-491,812,712.47-1,509,146,234.23-1,453,883,158.21-1,439,449,562.89
三、筹资活动产生的现金流量:
取得借款收到的现金1,835,264,148.924,065,122,989.153,295,700,0001,452,000,000
收到其他与筹资活动有关的现金115,663,953.84441,674,397.67302,040,538.77203,800,299.47
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,950,928,102.764,506,797,386.823,597,740,538.771,655,800,299.47
偿还债务支付的现金1,616,845,233.464,984,013,7003,698,946,4501,818,572,450
分配股利、利润或偿付利息支付的现金24,059,899.521,325,273,487.511,298,832,945.851,065,499,728.78
支付其他与筹资活动有关的现金149,591,388.611,305,607,391.48985,988,529.55646,543,558.47
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,790,496,521.597,614,894,578.995,983,767,925.43,530,615,737.25
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额160,431,581.17-3,108,097,192.17-2,386,027,386.63-1,874,815,437.78
四、汇率变动对现金及现金等价物的影响27,345,563.8540,121,088.5330,638,811.2414,617,987.23
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-334,437,929.39651,814,747.011,075,014,448.94-1,029,154,720.12
加:期初现金及现金等价物余额4,780,614,442.734,128,799,695.724,128,799,695.724,128,799,695.72
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额4,446,176,513.344,780,614,442.735,203,814,144.663,099,644,975.6
补充资料:
净利润-3,180,949,695.48-1,370,843,964.88
资产减值准备-5,415,349.06-1,409,550.67
固定资产和投资性房地产折旧-1,311,010,852.63-656,891,785.92
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,311,010,852.63-656,891,785.92
无形资产摊销-37,303,367.68-18,764,091.74
长期待摊费用摊销-26,321,001.29-11,754,144.38
处置固定资产、无形资产和其他长期资产的损失--2,679,296.59--2,456,981.19
固定资产报废损失-43,033,940.23-10,544,391.58
公允价值变动损失-38,116,002.85-29,113,667.6
财务费用-75,739,035.49-28,309,595.74
投资损失--7,627,189.35--2,532,420.46
递延所得税-48,141,185.11-9,136,895
其中:递延所得税资产减少-30,436,785.37-8,504,295.43
递延所得税负债增加-17,704,399.74-632,599.57
存货的减少-1,128,652,537.16-803,149,927.1
经营性应收项目的减少--23,422,883.89--56,057,659.74
经营性应付项目的增加--644,846,543.75--621,662,905.87
其他-3,715,965.28-3,933,692.75
现金的期末余额-4,780,614,442.73-3,099,644,975.6
减:现金的期初余额-4,128,799,695.72-4,128,799,695.72
公告日期2024-04-092024-03-192023-10-192023-08-19
审计意见(境内)标准无保留意见
TOP↑